St. Jude Medical Plan to Acquire Spinal Modulation for US$ 215 Million
St. Jude Medical has announced that it has exercised the companys exclusive option to acquire Spinal Modulation, Inc., developer of […]
Tags: Axium Neurostimulator System, california, Chief Operating Officer, chronic pain, chronic pain portfolio, chronic pain product portfolio, David Wood, device maker, dorsal root ganglion, Health/Medical/Pharmaceuticals, innovative therapy, M&A, Menlo Park, Michael T. Rousseau, Mind, Minnesota, nervous system, Neural engineering, Neuropathic pain, neurosurgery, Neurotechnology, Nociception, pain, patient’s chronic pain condition, Perception, president and chief utive officer, Spinal cord stimulator, Spinal Modulation Inc., st jude medical inc, St. Jude Medical’s mission, USD
